When.com Web Search

  1. Ads

    related to: latest treatments for dementia patients

Search results

  1. Results From The WOW.Com Content Network
  2. ‘Major breakthrough’ as dementia drug found to ‘slow ...

    www.aol.com/major-breakthrough-dementia-drug...

    A dementia charity has hailed a “historic moment” in Alzheimer’s research as a new drug has been found to reduce memory decline among patients with early-stage disease.

  3. A new study found that Alzheimer's medications called cholinesterase inhibitors may help slow down cognitive decline in people with dementia with Lewy bodies.

  4. Psychological therapies for dementia - Wikipedia

    en.wikipedia.org/wiki/Psychological_therapies...

    Design draft for a reality orientation board used to help people with dementia or in post-operative delirium. The aim of cognition-oriented treatments, which include reality orientation and cognitive retraining is the restoration of cognitive deficits. Reality orientation consists in the presentation of information about time, place or person ...

  5. Study challenges current views about toxic plaque formation ...

    www.aol.com/study-challenges-current-views-toxic...

    New research shows that glial cells play an important role in producing amyloid beta, a protein linked to Alzheimer’s disease. The study, undertaken by scientists at the Max Planck Institute ...

  6. Aducanumab - Wikipedia

    en.wikipedia.org/wiki/Aducanumab

    Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. [2] [3] It is a monoclonal antibody [3] [2] that targets aggregated forms (plaque) [4] [5] of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.

  7. Anti-amyloid drugs - Wikipedia

    en.wikipedia.org/wiki/Anti-amyloid_drugs

    Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. [23] [24] Lecanemab is an amyloid beta-directed antibody. [23] It is given via intravenous infusion to patients with mild cognitive impairment or mild dementia. [23]

  1. Ads

    related to: latest treatments for dementia patients